SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015636
Filing Date
2021-11-12
Accepted
2021-11-12 07:10:40
Documents
91
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ganx-20210930x10q.htm   iXBRL 10-Q 1923844
2 EX-10.1 ganx-20210930xex10d1.htm EX-10.1 492583
3 EX-31.1 ganx-20210930xex31d1.htm EX-31.1 10297
4 EX-31.2 ganx-20210930xex31d2.htm EX-31.2 10231
5 EX-32.1 ganx-20210930xex32d1.htm EX-32.1 9875
6 GRAPHIC ganx-20210930xex10d1001.jpg GRAPHIC 13267
7 GRAPHIC ganx-20210930xex10d1005.jpg GRAPHIC 719
8 GRAPHIC ganx-20210930xex10d1004.jpg GRAPHIC 735
9 GRAPHIC ganx-20210930xex10d1003.jpg GRAPHIC 8586
10 GRAPHIC ganx-20210930xex10d1007.jpg GRAPHIC 2478
11 GRAPHIC ganx-20210930xex10d1008.jpg GRAPHIC 4345
12 GRAPHIC ganx-20210930xex10d1009.jpg GRAPHIC 9092
13 GRAPHIC ganx-20210930xex10d1006.jpg GRAPHIC 3435
14 GRAPHIC ganx-20210930xex10d1011.jpg GRAPHIC 691
  Complete submission text file 0001558370-21-015636.txt   7803370

Data Files

Seq Description Document Type Size
15 EX-101.SCH ganx-20210930.xsd EX-101.SCH 55053
16 EX-101.CAL ganx-20210930_cal.xml EX-101.CAL 53073
17 EX-101.DEF ganx-20210930_def.xml EX-101.DEF 204478
18 EX-101.LAB ganx-20210930_lab.xml EX-101.LAB 476294
19 EX-101.PRE ganx-20210930_pre.xml EX-101.PRE 358763
20 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20210930x10q_htm.xml XML 1103030
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 211399511
SIC: 2834 Pharmaceutical Preparations